NCT02434822View on ClinicalTrials.gov

A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic

PHASE3CompletedINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

July 31, 2016

Conditions
Cholera
Interventions
BIOLOGICAL

Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

1.5 mL, Oral administration

BIOLOGICAL

Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

1.5 mL, Oral administration

BIOLOGICAL

Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

1.5 mL, Oral administration

Trial Locations (1)

Unknown

Santo Domingo

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT02434822 - A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic | Biotech Hunter | Biotech Hunter